No pricks: Oral TB drug for under 5 gets nod

Delamanid approval for under 5 children in India in March revolutionizes paediatric TB treatment, eliminating painful injectables. Central TB Division broadens Delamanid use for MDR-TB and XDR-TB, praised by Dr Sushant Mane and Dr Vikas Oswal.